drugset / Trial / NCT00318162
Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
Phase 1/2
Unknown
50 enrolled
Hadassah Medical Organization
Jerusalem Institute for Child Development · collab
RandomizedCrossoverDouble-blindTreatment
Summary
This study will examine the effects of low-dose naltrexone (LDN) on children with autistic spectrum disorders. The investigators hope to show a positive effect on social functioning and language.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | — | — |